Veterinary Pharmaceuticals Market Opportunities And Strategies To 2032

Veterinary Pharmaceuticals Market 2023 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By End User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores), By Route Of Administration (Oral, Other Route Of Administration), By Type Of Animal (Livestock, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 | Pages : 312 | Published : January 2023 | | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2032

Proud Members Of

Veterinary Pharmaceuticals Market Definition

The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals by entities (organizations, sole traders, and partnerships) that manufacture veterinary pharmaceuticals (or drugs) used to sedate, treat animal diseases, and/or to improve animals’ performance and health. The veterinary pharmaceuticals industry includes establishments that manufacture veterinary pharmaceuticals such as veterinary vaccines, veterinary antibiotics, and other veterinary pharmaceuticals.

Veterinary pharmaceuticals or veterinary drugs are those products which achieve their effect through chemical reaction or metabolism in the body.

Veterinary Pharmaceuticals Market Size

The global veterinary pharmaceuticals market size reached a value of nearly $ 25,993.9 million in 2021, having increased at a compound annual growth rate (CAGR) of 4.6% since 2016. The market is expected to grow from $ 25,993.9 million in 2021 to $ 35,301.4 million in 2026 at a rate of 6.3%. The global veterinary pharmaceuticals market size is then expected to grow at a CAGR of 5.6% from 2026 and reach $ 46,398.0 million in 2031.

Growth in the historic period resulted from increased pet population, increased the overall spending of individuals on pets, growing penetration of e-commerce platforms promoting online pharmacies, rise in animal healthcare expenditure, emerging markets growth, increased pet insurance, increasing government initiatives, increased companion animal ownership, increased disease prevalence and increased outbreak of poultry diseases. Factors that negatively affected growth in the historic period were the coronavirus (COVID-19) outbreak, lack of awareness and inappropriate use of medicines.

Going forward, increasing prevalence of zoonotic diseases, increase in the prevalence rate of diseases, increasing pet ownership, increasing population growth, increasing disposable income and increasing urbanization attributed to market growth. Factors that could hinder the growth of the veterinary pharmaceuticals market in the future include shortage of veterinarians, lack of infrastructure for providing emergency veterinary services, stringent rules and regulations in animal testing and restrictions, high cost associated with animal healthcare drugs in low-middle income countries, consolidation of customers and distributors and increasing influx of counterfeit drugs.

Veterinary Pharmaceuticals Market Drivers

The key drivers of the veterinary pharmaceuticals market include:

Increasing Prevalence of Zoonotic Diseases

The increase in prevalence of zoonotic diseases is expected to propel the growth of the veterinary pharmaceuticals market during the forecast period. People living adjacent to wilderness areas or in semi-urban areas with higher numbers of wild animals are at risk of disease from animals such as rats, foxes or raccoons. Urbanization and the destruction of natural habitats increase the risk of zoonotic diseases by increasing contact between humans and wild animals.

For instance, in July 2021, according to Centers for Disease Control and Prevention, a US-based Government Agency, Zoonotic diseases are very common, both in the United States and around the world. Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals. Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary pharmaceuticals market during forecast period.

Veterinary Pharmaceuticals Market Restraints

The key restraints on the veterinary pharmaceuticals market include:

Shortage of Veterinarians

A shortage of veterinarians is restraining the growth of the veterinary pharmaceuticals market during the forecast period. The veterinary shortage has put a huge amount of pressure on professionals. In the long term, changes in pay, work-life balance, and client expectations have driven dissatisfaction. In the short term, the pandemic has increased practice inefficiency, and therefore backlogs, exacerbating shortages.

For instance, in March 2022, according to Mars Veterinary Health, a US-based provider of veterinary care and employer of veterinary professionals, with an average of 2,500-2,600 graduates becoming veterinarians each year, there is an estimated 15,000 veterinarian shortage for U.S. animals by 2030.According to Banfield Pet Hospital, a US-based private company. a potential shortage of this size would leave 75 million pets without veterinary care by 2030. Therefore, the shortage of veterinarians is restraining the growth of the veterinary pharmaceuticals market during the forecast period.

Veterinary Pharmaceuticals Market Trends

Major trends shaping the veterinary pharmaceuticals market include the following –

Stem Cell Therapy To Treat Animals

Stem cell therapy is increasingly being used by veterinary pharmaceuticals to treat orthopedic conditions such as osteoarthritis, ligament injuries and tendons.

Stem cell therapy helps to restore motion and stimulate the regeneration of tendon, ligament and joint tissues by isolating adult stem cells from an animals’ fat tissue and re-introducing these cells to reduce pain and inflammation.

Some of the companies offering stem cell therapy in the USA include VetStem and MediVet.

For instance, in April 2019, Boehringer Ingelheim, a German pharmaceutical company, launched Arti-Cell Forte in Europe for the reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.

Arti-Cell Forte is a groundbreaking first-ever approved therapy, developed towards targeting lameness, utilizing specifically primed, chondrogenic induced stem cells. Arti-Cell® Forte is available in an ultra-low frozen, ready-to-use format.

Use Of Artificial Intelligence

The companies in the veterinary pharmaceuticals market are using artificial intelligence (AI) to help veterinarians broaden diagnostic offerings to provide the best possible care for dogs and cats.

Artificial intelligence is a machine-based learning which makes use of human intelligence functionalities like reasoning and problem-solving abilities to obtain insights and provide useful information. Companies in the market are deploying AI applications to provide the best possible care for animals.

For example, in April 2022, Zoetis Inc., an American drug company, launched artificial intelligence (AI) based blood smear testing on its multi-purpose platform, Vetscan ImagystTM.

Similarly, in 2019, Techcyte, a US-based leading developer of AI-based image analysis solutions for the diagnostics industry, launched Vetcyte, an AI-powered digital diagnostics platform at VMX 2019. The Vetcyte AI-based image analysis platform supports digital diagnostics in the veterinary industry.

Opportunities and Recommendations In Veterinary Pharmaceuticals Market

Opportunities –The top growth potential in the veterinary pharmaceuticals market by type will arise in the veterinary parasiticides market, which will gain $ 3,561.4 million of global annual sales by 2026. The top growth potential in the veterinary pharmaceuticals market by end user will arise in the veterinary hospitals market, which will gain $ 6,571.3 million of global annual sales by 2026. The top growth potential in the veterinary pharmaceuticals market by route of administration will arise in oral market, which will gain $ 5,502.3 million of global annual sales by 2026. The top growth potential in the veterinary pharmaceuticals market by type of animal will arise in companion animals market, which will gain $ 6,482.2 million of global annual sales by 2026. The top growth potential in the veterinary pharmaceuticals market by type of vaccine will arise in inactivated vaccines market, which will gain $ 1,125.7 million of global annual sales by 2026. The veterinary pharmaceuticals market size will gain the most in the USA at $3,034.8 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the veterinary pharmaceuticals companies to focus on stem cell therapy to treat animals, focus on application of nanotechnology in veterinary medicines, focus on development of chewable tablets, focus on use of next generation sequencing (NGS), focus on development of vaccines, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users.

Veterinary Pharmaceuticals Market Segmentation

The veterinary pharmaceuticals market is segmented by type, by end-user, by route of administration, by type of animal, and by type of vaccine.
By Type –
The veterinary pharmaceuticals market is segmented by type into
    • a) Veterinary Vaccines
    • b) Veterinary Antibiotics
    • c) Veterinary Parasiticides
    • d) Other Veterinary Pharmaceuticals
The veterinary parasiticides was the largest segment of the veterinary pharmaceuticals market by type, accounting for $11,267.8 million or 43.3% of the total market in 2021. The veterinary parasiticides market is expected to be the fastest-growing segment going forward at a CAGR of 5.0%.
By End-User –
The veterinary pharmaceuticals market is segmented by end-user into
    • a) Veterinary Hospitals
    • b) Veterinary Clinics
    • c) Pharmacies And Drug Stores
The veterinary hospitals market was the largest segment of the veterinary pharmaceuticals market by end user, accounting for $ 17,357.4 million or 66.8% of the total market in 2021. The veterinary hospitals market is expected to be the fastest-growing segment going forward at a CAGR of 5.6%.
By Route Of Administration –
The veterinary pharmaceuticals market is segmented by route of administration into
    • a) Oral
    • b) Other Route Of Administration
The oral was the largest segment of the veterinary pharmaceuticals market by application, accounting for $14,477.6 million or 55.7% of the total market in 2021. The oral market is expected to be the fastest-growing segment going forward at a CAGR of 6.0%.
By Type Of Animal –
The veterinary pharmaceuticals market is segmented by type of animal into
    • a) Livestock
    • b) Companion Animals
The livestock was the largest segment of the veterinary pharmaceuticals market by application, accounting for $ 13,985.1 million or 53.8% of the total market in 2021. The livestock market is expected to be the fastest-growing segment going forward at a CAGR of 3.0%.
By Type Of Vaccine –
The veterinary pharmaceuticals market is segmented by type of vaccine into
    • a) Inactivated Vaccines
    • b) Attenuated Vaccines
    • c) Recombinant Vaccines
    • d) Other Vaccines
The live attenuated vaccines was the largest segment of the veterinary pharmaceuticals market by application, accounting for $4,017.1 million or 15.5% of the total market in 2021. The live attenuated vaccines market is expected to be the fastest-growing segment going forward at a CAGR of 5.6%.
By Geography - The veterinary pharmaceuticals market is segment by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the veterinary pharmaceuticals market, accounting for 48.3% of the global market in 2022. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the veterinary pharmaceuticals market will be Middle East and the Africa, where growth will be at CAGRs of 13.3% and 11.7% respectively from 2021-2026.

Veterinary Pharmaceuticals Competitive Landscape

Major Competitors are:

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale
  • Other Competitors Include:

  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Kyoritsu Seiyaku Corporation
  • Century Pharmaceuticals Limited
  • BASF India Ltd
  • Bayer Animal Health
  • Cadila Pharmaceuticals Ltd
  • Cargill India Pvt. Ltd
  • Zoetis India
  • China Animal Healthcare Ltd
  • Merck/MSD Animal Health
  • Intervet Australia Pty Ltd
  • Virbac (Australia) Pty Limited
  • Jurox Pty Ltd
  • Nimrod Veterinary Products Ltd.
  • Bimeda
  • Vetoquinol SA
  • Orion Animal Health
  • Laboratorios Calier, SA
  • Dechra Pharmaceuticals
  • Petmedix
  • Eco Animal Health
  • Teknofarma
  • Farmavet
  • Candioli Pharma
  • Suanfarma
  • Marino Ibericamed
  • MPA veterinary
  • Lamons Laboratories SA
  • SUPER'S DIANA
  • Swetrade Pharmaceuticals AB
  • Animalcare
  • VIC Animal Health
  • AVZ animal health
  • Provet Group
  • VitOMEK LCC
  • Micro-plus
  • Biowet
  • Bioveta
  • Brovapharma
  • Evrovet
  • Ukrvetprompostach
  • VELELEK d.o.o
  • Veterinarski Zavod Subotica
  • VetPlanet
  • Delos Medica
  • Vetro Solutions
  • Belfarmacom
  • Veterinary Purchasing Co. Ltd
  • Centre Vétérinaire Laval
  • P3 Veterinary Partners
  • Audrain Veterinary Clinic
  • Fuzzy
  • Bond Vet
  • The Vets
  • Small Door Veterinary, Modern Animal
  • Heska Corporation
  • IDT Biologika
  • Elanco Animal Health
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health USA Inc
  • Ceva Animal Health Inc
  • Maure
  • Mimados
  • Peru Animal Hospital
  • Miami County Veterinary Clinic
  • Cindy Fouts
  • Kokomo Animal Hospital
  • UCBVET
  • Syntec
  • Sauvet
  • Vetanco
  • Chemo Argentina
  • Brouwer
  • Agrovet Market Animal Health
  • Lemavet
  • Primo Veterinary Medicines Trading LLC
  • AL KUBARA VETERINARY MEDICINES TRADING LL
  • Eurovets Veterinary Suppliers
  • Physio Evolution
  • Vet Hospital Emergency Care For dogs
  • Herzliya Veterinary Hospital
  • Veterinarian Animal Hospital souvenir houses
  • Oron Veterinary Center
  • Dr Aviram Ezra – Veterinarian
  • Boehringer Ingelheim MENA
  • Saudi Pharmaceutical Industries (SPI)
  • DBK Pharma S.A.E
  • Dawa Limited
  • Aesthetics Limited
  • Dolek Pharmaceutical
  • Neimeth International Pharmaceuticals
  • Osy-Adamu Pharmaceutical Co
  • M S J Afro Agro Pharmacy
  • Global Vet (U) Ltd
  • Multivet Ghana Ltd
    1. Table Of Contents

      1. Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction and Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Veterinary Pharmaceuticals Market Definition and Segmentations

      6.4. Market Segmentation By Type

      6.4.1. Veterinary Vaccines

      6.4.2. Veterinary Antibiotics

      6.4.3. Veterinary Parasiticides

      6.4.4. Other Veterinary Pharmaceuticals

      6.5. Market Segmentation By End User

      6.5.1. Veterinary Hospitals

      6.5.2. Veterinary Clinics

      6.5.3. Pharmacies And Drug Stores

      6.6. Market Segmentation By Route Of Administration

      6.6.1. Oral

      6.6.2. Other Route Of Administration

      6.7. Market Segmentation By Type Of Animal

      6.7.1. Livestock

      6.7.2. Companion Animals

      6.8. Market Segmentation By Type Of Vaccine

      6.8.1. Inactivated Vaccines

      6.8.2. Attenuated Vaccines

      6.8.3. Recombinant Vaccines

      6.8.4. Other Vaccines

      7. Major Trends And Strategies

      7.1. Stem Cell Therapy To Treat Animals

      7.2. Use Of Artificial Intelligence

      7.3. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance

      7.4. Use Of Microchipping Technology

      7.5. Development Of Chewable Tablets

      7.6. Use Of Telemedicine Platforms To Reduce The Impact Of COVID-19

      7.7. Increasing Technological Advancements

      7.8. Use Of Next Generation Sequencing (NGS)

      7.9. Development Of Vaccines

      7.10. Super-Combo Parasiticides

      7.11. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines

      8. Global Market Size And Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      8.2.1. Market Drivers 2016 – 2021

      8.2.2. Increased Disease Prevalence

      8.2.3. Market Restraints 2016 – 2021

      8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      8.3.1. Market Drivers 2021 – 2026

      8.3.2. Market Restraints 2021 – 2026

      9. Global Market Segmentation

      9.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.2. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.4. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      9.5. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10. Global Market, Regional And Country Analysis

      10.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      10.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Tax Levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.4. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.7. Asia Pacific Veterinary Pharmaceuticals Market: Country Analysis

      11.8. China Market

      11.9. Summary

      11.10. Market Overview

      11.10.1. Country Information

      11.10.2. Market Information

      11.10.3. Background Information

      11.10.4. Government Initiatives

      11.10.5. Regulations

      11.10.6. Regulatory Bodies

      11.10.7. Major Associations

      11.10.8. Corporate Tax Structure

      11.10.9. Taxes Levied

      11.10.10. Investments

      11.10.11. Major Companies

      11.11. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.12. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.13. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.14. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.15. India Market

      11.16. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.17. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.18. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.19. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.20. Japan Market

      11.21. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.22. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.23. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.24. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.25. Australia Market

      11.26. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.27. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.28. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.29. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.30. Indonesia Market

      11.31. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.32. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.33. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.34. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.35. South Korea Market

      11.36. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      11.37. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      11.38. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.39. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.4. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis

      12.8. UK Market

      12.9. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.10. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.12. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.13. Germany Market

      12.14. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.15. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.16. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.17. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.18. France Market

      12.19. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      12.20. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      12.21. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.22. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Tax Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.4. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis

      13.8. Russia Market

      13.9. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.4. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.5. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.7. North America Veterinary Pharmaceuticals Market: Country Analysis

      14.8. USA Market

      14.9. Summary

      14.10. Market Overview

      14.10.1. Country Information

      14.10.2. Market Information

      14.10.3. Background Information

      14.10.4. Government Initiatives

      14.10.5. Regulations

      14.10.6. Regulatory bodies

      14.10.7. Major Associations

      14.10.8. Taxes Levied

      14.10.9. Corporate Tax Structure

      14.10.10. Investments

      14.10.11. Major Companies

      14.11. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.12. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.13. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.14. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.4. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.5. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.7. South America Veterinary Pharmaceuticals Market: Country Analysis

      15.8. Brazil Market

      15.9. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.10. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.4. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.4. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Competitive Landscape And Company Profiles

      18.1. Company Profiles

      18.2. Zoetis Inc

      18.2.1. Company Overview

      18.2.2. Products And Services

      18.2.3. Business Strategy

      18.2.4. Financial Overview

      18.3. Merck & Co., Inc.

      18.3.1. Company Overview

      18.3.2. Products And Services

      18.3.3. Business Strategy

      18.3.4. Financial Overview

      18.4. Boehringer Ingelheim International GmbH

      18.4.1. Company Overview

      18.4.2. Products And Services

      18.4.3. Business Strategy

      18.4.4. Financial Overview

      18.5. Elanco Animal Health Incorporated

      18.5.1. Company Overview

      18.5.2. Products And Services

      18.5.3. Business Strategy

      18.5.4. Financial Overview

      18.6. Ceva Sante Animale

      18.6.1. Company Overview

      18.6.2. Products And Services

      18.6.3. Business Strategy

      18.6.4. Financial Overview

      19. Key Mergers and Acquisitions

      19.1. Vimian Group Acquired Heiland GmbH

      19.2. Dechra Acquired Med-Pharmex

      19.3. Bimeda Acquired Afrivet

      19.4. Dechra Pharmaceuticals Acquired Piedmont Animal Health

      19.5. Virbac Acquired Assets Of Elanco Animal Health Inc.

      19.6. Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

      19.7. Swedencare AB Acquired Animal Pharmaceuticals Inc.

      19.8. Elanco Animal Health Acquired Bayer Animal Health

      19.9. MSD Animal Health Acquired Worldwide Rights of VECOXAN from Elanco Health

      19.10. Boehringer Ingelheim Acquired Global Stem cell Technology

      19.11. Merck & Co. Inc. Announced The Acquisition Of Virbac’s Anti-Parasitic Portfolio

      19.12. The Carlyle Group Acquired SeQuent Scientific Ltd.

      19.13. Friulchem Acquired Pharmabbie

      19.14. Manna Pro Acquired Promika, LLC Pet Brands

      20. Opportunities And Strategies

      20.1. Global Veterinary Pharmaceuticals Market In 2026 – Countries Offering Most New Opportunities

      20.2. Global Veterinary Pharmaceuticals Market In 2026 – Segments Offering Most New Opportunities

      20.3. Global Veterinary Pharmaceuticals Market In 2026 – Growth Strategies

      20.3.1. Market Trend Based Strategies

      20.3.2. Competitor Strategies

      21. Veterinary Pharmaceuticals Market, Conclusions And Recommendations

      21.1. Conclusions

      21.2. Recommendations

      21.2.1. Product

      21.2.2. Place

      21.2.3. Price

      21.2.4. Promotion

      21.2.5. People

      22. Appendix

      22.1. Market Data Sources

      22.2. Research Methodology

      22.3. Currencies

      22.4. The Business Research Company

      22.5. Copyright and Disclaimer

      22.6.

    List Of Tables

      Table 1: Global Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 14: Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 15: Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 16: Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 17: Asia-Pacific Livestock Population, 2015-2020, Thousands
    • Table 18: Asia-Pacific Number of Dogs, 2015-2020, Thousands
    • Table 19: Asia-Pacific Number of Cats, 2015-2020, Thousands
    • Table 20: Asia Pacific Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 21: Asia-Pacific, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 22: Asia-Pacific Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 23: Asia-Pacific Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 24: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 25: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 26: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 27: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 28:  China Livestock Population, 2015-2020, Thousands
    • Table 29:  China Number of Dogs, 2015-2020, Thousands
    • Table 30:  China Number of Cats, 2015-2020, Thousands
    • Table 31: Asia Pacific Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 32: China Veterinary Services Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Billion
    • Table 33: China Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 34: China Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 35: China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 36: China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 37: China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 38: China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 39: India Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 40: India Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 41: India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 42: India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 43: India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 44: India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 45: Japan Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 46: Japan Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 47: Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 48: Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 49: Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 50: Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 51: Australia Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 52: Australia Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 53: Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 54: Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 55: Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 56: Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 57: Indonesia Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 58: Indonesia Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 59: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 60: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 61: Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 62: Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 63: South Korea Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 64: South Korea Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 65: South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 66: South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 67: South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 68: South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 69:  Western Europe Livestock Population, 2015-2020, Thousands
    • Table 70:  Western Europe Number of Dogs, 2015-2020, Thousands
    • Table 71:  Western Europe Number of Cats, 2015-2020, Thousands
    • Table 72: Western Europe Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 73: Western Europe, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 74: Western Smart Europe Washing Machines Market, Historic, 2016 – 2021, $ Million
    • Table 75: Western Europe Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 76: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 77: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 78: Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: UK Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 81: UK Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 82: UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 83: UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 84: UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 85: UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 86: Germany Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 87: Germany Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 88: Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 89: Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 90: Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 91: Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 92: France Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 93: France Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 94: France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 95: France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 96: France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 97: France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 98:  Eastern Europe Livestock Population, 2015-2020, Thousands
    • Table 99:  Eastern Europe Number of Dogs, 2015-2020, Thousands
    • Table 100:  Eastern Europe Number of Cats, 2015-2020, Thousands
    • Table 101: Eastern Europe Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 102: Eastern Europe, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 103: Eastern Europe Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 104: Eastern Europe Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 105: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 106: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 107: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 108: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 109: Russia Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 110: Russia Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 111: Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 112: Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 113: Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 114: Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 115:  North America Livestock Population, 2015-2020, Thousands
    • Table 116:  North America Number of Dogs, 2015-2020, Thousands
    • Table 117:  North America Number of Cats, 2015-2020, Thousands
    • Table 118: North America Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 119: North America, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 120: North America Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 121: North America Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 122: North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 123: North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 124: North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 125: North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 126:  USA Livestock Population, 2015-2020, Thousands
    • Table 127:  USA Number of Dogs, 2015-2020, Thousands
    • Table 128:  USA Number of Cats, 2015-2020, Thousands
    • Table 129: USA Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 130: USA, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 131: USA Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 132: USA Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 133: USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 134: USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 135: USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 136: USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 137:  South America Livestock Population, 2015-2020, Thousands
    • Table 138:  South America Number of Dogs, 2015-2020, Thousands
    • Table 139:  South America Number of Cats, 2015-2020, Thousands
    • Table 140: South America Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 141: South America, Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 142: South America Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 143: South America Washing Machines Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 144: South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 145: South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 146: South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 147: South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 148: Brazil Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 149: Brazil Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 150: Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 151: Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 152: Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 153: Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 154:  Middle East Livestock Population, 2015-2020, Thousands
    • Table 155:  Middle East Number of Dogs, 2015-2020, Thousands
    • Table 156:  Middle East Number of Cats, 2015-2020, Thousands
    • Table 157: Middle East Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 158: Middle East Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 159: Middle East Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 160: Middle East Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 161: Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 162: Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 163: Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 164: Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 165:  Africa Livestock Population, 2015-2020, Thousands
    • Table 166:  Africa Number of Dogs, 2015-2020, Thousands
    • Table 167:  Africa Number of Cats, 2015-2020, Thousands
    • Table 168: Africa Animal Medicine Market Size, Historic And Forecast, 2016 – 2021, 2026F, $ Million
    • Table 169: Africa Veterinary Services Market Size, By Country, 2016-2026, $ Million
    • Table 170: Africa Veterinary Pharmaceuticals Market, Historic, 2016 – 2021, $ Million
    • Table 171: Africa Veterinary Pharmaceuticals Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 172: Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 173: Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 174: Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 175: Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 176: Global Veterinary Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 177: Zoetis – Financial Performance, 2017– 2021, $ Billion
    • Table 178: Merck & Co – Financial Performance, 2017– 2021, $ Billion
    • Table 179: Boehringer Ingelheim – Financial Overview, 2017 - 2021, $ Billion
    • Table 180: Elanco Animal Health – Financial Performance, 2017– 2021, $ Billion
    • Table 181: Ceva – Financial Performance, 2021, $ Billion
    • Table 182: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 183: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
    • Table 184: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By End User, 2021 – 2026
    • Table 185: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Route Of Administration, 2021 – 2026
    • Table 186: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type Of Animal, 2021 – 2026
    • Table 187: Global Veterinary Vaccines Market Size Gain ($ Million), Segmentation By Type Of Vaccine, 2021 – 2026
    • Table 188: Veterinary Pharmaceuticals Market Data Sources

    List Of Figures

      Figure 1: Global Veterinary Pharmaceuticals Market Segmentation By Type Of Pharmaceuticals
    • Figure 2: Global Veterinary Pharmaceuticals Market Segmentation By Animal Type
    • Figure 3: Global Veterinary Pharmaceuticals Market Segmentation By Route Of Administration
    • Figure 4: Global Veterinary Pharmaceuticals Market Segmentation By End Use Channel
    • Figure 5: Global Veterinary Vaccine Market Segmentation By Type Of Vaccine
    • Figure 6: Global Veterinary Antibiotics Market Segmentation By Type
    • Figure 7: Global Veterinary Pharmaceuticals Industry, Supply Chain Analysis
    • Figure 8: Global Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 9: Global Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 10: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2020, 2025F, 2030F, %
    • Figure 15: Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2020, 2025F, 2030F, %
    • Figure 16: Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, %
    • Figure 17: Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, %
    • Figure 18: Asia-Pacific Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 19: Asia-Pacific Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 20: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 21: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 24: Australia Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 25: Australia Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 26: Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025, 2030F, %
    • Figure 28: Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: China Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 31: China Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 36: Indonesia Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 37: Indonesia Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 38: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: India Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 43: India Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 45: India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025, 2030F, %
    • Figure 46: India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 48: Japan Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 49: Japan Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025, 2030F, %
    • Figure 52: Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: South Korea Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 55: South Korea Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 60: Western Europe Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 61: Western Europe Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 62: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 64: Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: France Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 67: France Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 68: France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Germany Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 73: Germany Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 74: Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 76: Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: UK Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 79: UK Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 80: UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 84: Eastern Europe Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 85: Eastern Europe Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 86: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 88: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 89: Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 90: Russia Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 91: Russia Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 92: Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 93: Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 94: Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 95: Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 96: North America Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 97: North America Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 98: North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 99: North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 100: North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 101: North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 102: USA Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 103: USA Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 104: USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 105: USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 106: USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 107: USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 108: South America Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 109: South America Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 110: South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 111: South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 112: South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 113: South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 114: Brazil Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 115: Brazil Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 116: Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 117: Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 118: Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 119: Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 120: Middle East Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 121: Middle East Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 122: Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 123: Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 124: Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 125: Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 126: Africa Veterinary Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
    • Figure 127: Africa Veterinary Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 128: Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 129: Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 130: Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 131: Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 132: Global Veterinary Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 133: Zoetis Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 134: Boehringer Ingelheim GmbH – Financial Performance, 2016 – 2020, $ Billion
    • Figure 135: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 136: Elanco Animal Health Incorporated –  Financial Performance, 2016 – 2020,$ Billion
    • Figure 137: Global Animal Medicine Market, Segmentation By Type Of Medicine, 2015 – 2025, $ Billion
    • Figure 138: Global Animal Medicine Market, 2020, Split By Region
    • Figure 139: Global Animal Medicine Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report